For most UK patients, the central medical-cannabis divide is not legal versus illegal. It is private versus NHS. Those who can fund consultations, follow-ups and medication may be able to pursue treatment; those who cannot are usually left with a legal right in theory and no realistic route in practice.
That is the pressure point patient groups are bringing back into public view.
Equality is the real argument
Campaigners describe the present arrangement as a two-tier system. Their case is broader than a demand that every patient receive cannabis-based medicine: they want comparable patients to receive a fair clinical assessment regardless of income.
That distinction matters. No responsible access campaign can promise that a prescription is appropriate for everyone. The stronger argument is that affordability should not decide who gets to have the conversation with an informed specialist.
Why the 2018 change did not settle access
When the law changed, public expectations moved faster than the health service. Prescribing remained confined to specialists, evidence standards were interpreted cautiously and local commissioning offered little certainty. Many clinicians received limited practical education. Private providers filled the resulting gap.
Parliamentary interest and cross-party concern keep the issue alive, but supportive speeches are not the same as an operational pathway. Patients need decisions about training, commissioning, evidence collection and responsibility for follow-up care.
What credible reform would look like
A serious NHS response would begin with consistent clinical guidance and a transparent route for appropriate cases. It would also collect outcomes in a form that can improve future decisions, rather than using gaps in evidence as a permanent reason to avoid learning.
Patient rights are not strengthened by pretending the evidence is simpler than it is. They are strengthened when uncertainty is handled openly, clinical decisions are accountable and ability to pay stops functioning as the main gateway.
The campaign therefore has a clear test for government: not another statement that prescribing is technically possible, but evidence that an eligible NHS patient can actually reach a fair assessment.
